“Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?”

Luminal breast cancers are hormone receptor (estrogen and/or progesterone) positive that are further divided into HER2-negative luminal A and HER2-positive luminal B subtypes. According to currently accepted convention, they represent the most common subtypes of breast cancer, accounting for approxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Höller, Anna, Nguyen-Sträuli, Bich Doan, Frauchiger-Heuer, Heike, Ring, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392911/
https://www.ncbi.nlm.nih.gov/pubmed/37533589
http://dx.doi.org/10.2147/BCTT.S340741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392911/
https://www.ncbi.nlm.nih.gov/pubmed/37533589
http://dx.doi.org/10.2147/BCTT.S340741

Ejemplares similares